The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liquid biopsies for faster diagnosis of suspected advanced pancreatic and biliary tract cancers: ACCESS, a UK innovation programme.
 
Lauren Jones
No Relationships to Disclose
 
Justin Mencel
No Relationships to Disclose
 
Reed Mullen
No Relationships to Disclose
 
Sofia Sardo Infirri
No Relationships to Disclose
 
Alan MacDonald
No Relationships to Disclose
 
Charlotte Victoria Fribbens
No Relationships to Disclose
 
Sheela Rao
Honoraria - Bayer; Incyte; Merck Serono; Servier (I)
Consulting or Advisory Role - AstraZeneca; Bayer
Travel, Accommodations, Expenses - SERVIER
 
Asif Mahmood
No Relationships to Disclose
 
Daniel Galloway
No Relationships to Disclose
 
Sanjay Gupta
No Relationships to Disclose
 
Georgina Chadwick
No Relationships to Disclose
 
Ian Chau
Honoraria - Bristol-Myers Squibb; Eisai; Lilly; Novartis; Roche/Genentech; SERVIER
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BioNTech SE; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; GlaxoSmithKline; Lilly; Merck Serono; MSD Oncology; OncXerna Therapeutics; Roche/Genentech; Seagen; SERVIER; Sotio; Taiho Oncology; Turning Point Therapeutics
Research Funding - Janssen-Cilag (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - BMS; SERVIER
 
Melody Ni
No Relationships to Disclose
 
Terri Patricia McVeigh
Honoraria - AstraZeneca; MSD; Roche
 
Sanjay Popat
Honoraria - Amgen; AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; EQRx; GlaxoSmithKline; Guardant Health; Incyte; Janssen; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Roche; Sanofi; Seagen; Takeda; Turning Point Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; EQRx; GlaxoSmithKline; Guardant Health; Incyte; Janssen; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Pfizer; Roche; Sanofi; Seagen; Takeda; Turning Point Therapeutics
Research Funding - Amgen (Inst); ARIAD (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Janssen (Inst); Lilly (Inst); Mirati Therapeutics; MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst); Trizell; Turning Point Therapeutics (Inst)
Expert Testimony - Merck KGaA; Roche
 
Michael Hubank
Honoraria - AstraZeneca; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; Cepton Strategies; GlaxoSmithKline; Incyte; Janssen; Novartis; Qiagen; Roche; Seagen; Simon Kucher
Other Relationship - Guardant Health (Inst)
 
David Cunningham
Stock and Other Ownership Interests - OVIBIO
Consulting or Advisory Role - OVIBIO
Research Funding - 4SC (Inst); Bayer (Inst); Clovis Oncology (Inst); Leap Oncology (Inst); Lilly (Inst); MedImmune (Inst); Roche (Inst)
 
Angela Joy George
Employment - AstraZeneca (I)
Honoraria - AstraZeneca; GlaxoSmithKline; MSD Oncology; Roche
Speakers' Bureau - AstraZeneca/Merck; GlaxoSmithKline
 
Naureen Starling
Honoraria - Amgen; AstraZeneca; BMS; BMS; GlaxoSmithKline; GlaxoSmithKline; Lilly; Lilly; Merck; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Novartis; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Seagen; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; GlaxoSmithKline; Janssen; MSD; MSD Oncology; MSD Oncology; Novartis Pharmaceuticals UK Ltd.; Pfizer; Seagen; SERVIER
Research Funding - AstraZeneca (Inst); BMS (Inst); Guardant Health (Inst); Merck Serono (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Guardant Health; MSD Oncology; SERVIER
(OPTIONAL) Uncompensated Relationships - Guardant Health